Antimetabolite Immunosuppressant drugs compared
Compare all 3 Antimetabolite Immunosuppressant drugs side by side, used for conditions such as graft vs host disease, psoriasis. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores.
Full ranking · 3 drugs
- 170/100
myfortic
Mycophenolate Sodium
- 2New
cellcept
Mycophenolate Mofetil
- 3New
mycophenolate mofetil
Mycophenolate Mofetil
Frequently asked questions
What is the Antimetabolite Immunosuppressant drug class?
Antimetabolite Immunosuppressant is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 3 Antimetabolite Immunosuppressant products, each independently rated.
Are all Antimetabolite Immunosuppressant drugs the same?
No. Antimetabolite Immunosuppressant drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
What conditions do Antimetabolite Immunosuppressant drugs treat?
Per NIH RxClass drug-classification data, Antimetabolite Immunosuppressant drugs are used for conditions including graft vs host disease, psoriasis.
Sources: the Antimetabolite Immunosuppressant class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.